Amplification of aminoglycoside resistance gene aphA1 in Acinetobacter baumannii results in tobramycin therapy failure
about
Code blue: Acinetobacter baumannii, a nosocomial pathogen with a role in the oral cavityThe genomic diversification of the whole Acinetobacter genus: origins, mechanisms, and consequencesMovement of IS26-associated antibiotic resistance genes occurs via a translocatable unit that includes a single IS26 and preferentially inserts adjacent to another IS26.Analysis of Serial Isolates of mcr-1-Positive Escherichia coli Reveals a Highly Active ISApl1 Transposon.War wound treatment complications due to transfer of an IncN plasmid harboring bla(OXA-181) from Morganella morganii to CTX-M-27-producing sequence type 131 Escherichia coli.Clinically Relevant Growth Conditions Alter Acinetobacter baumannii Antibiotic Susceptibility and Promote Identification of Novel Antibacterial Agents.A novel method of consensus pan-chromosome assembly and large-scale comparative analysis reveal the highly flexible pan-genome of Acinetobacter baumanniiOrigin in Acinetobacter gyllenbergii and dissemination of aminoglycoside-modifying enzyme AAC(6')-Ih.In vivo efficacy of humanized high dose meropenem and comparators against Pseudomonas aeruginosa isolates producing verona integron-encoded metallo-β-lactamase (VIM).Tracking Cefoperazone/Sulbactam Resistance Development In vivo in A. baumannii Isolated from a Patient with Hospital-Acquired Pneumonia by Whole-Genome SequencingWhole-Genome Sequencing Identifies In Vivo Acquisition of a blaCTX-M-27-Carrying IncFII Transmissible Plasmid as the Cause of Ceftriaxone Treatment Failure for an Invasive Salmonella enterica Serovar Typhimurium InfectionSelection and evolution of resistance to antimicrobial drugs.Antibacterial activity of human simulated epithelial lining fluid concentrations of amikacin inhale alone and in combination with meropenem against Acinetobacter baumannii.Emerging resistance to aminoglycosides in lactic acid bacteria of food origin-an impending menace.Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.Pseudomonas Endocarditis with an unstable phenotype: the challenges of isolate characterization and Carbapenem stewardship with a partial review of the literature.A novel gene amplification causes upregulation of the PatAB ABC transporter and fluoroquinolone resistance in Streptococcus pneumoniaeAntibacterial activity of achievable epithelial lining fluid exposures of Amikacin Inhale with or without meropenem.Fatal outbreak of an emerging clone of extensively drug-resistant Acinetobacter baumannii with enhanced virulence.Deciphering multifactorial resistance phenotypes in Acinetobacter baumannii by genomics and targeted label-free proteomics.Extensive Gene Amplification as a Mechanism for Piperacillin-Tazobactam Resistance in Escherichia coli.Aminoglycoside Heteroresistance in Acinetobacter baumannii AB5075
P2860
Q26996396-CBD6A9F7-2BE5-487C-B501-EEDCFC105256Q28652539-3BAB1EB4-F678-45B5-B260-D3BB501AF74AQ30858027-06CC878C-672E-4D8F-BB90-6BC0CC0C19B8Q33601780-CBC86673-F761-4CBE-AD54-9D85984E3903Q35607676-0E7E10A1-7C7F-4FE7-BA80-1C0D62ACA79EQ35838503-03653624-55B4-47B9-ABD8-5A8C7C3FDF7DQ35865965-3B501B3A-0AF7-4502-8D9E-4BBE4AF60D8DQ36551321-74383177-C833-4844-B4C2-A0326CE1D7BBQ37097371-A5AF2EEC-84F3-4EB9-9935-59B8B18B2178Q37188148-76ACB46F-865B-4554-8F61-4821F291C271Q37428648-1A6D27D2-C4CC-44E6-9648-662E0BED3390Q38220609-FFA50BCF-E030-48B1-90FB-64C2B657E98DQ38652103-E9ED3C18-363F-49EC-8702-0B66B5116618Q38657199-8A4BB919-CE8D-4E50-A6CF-2051B45A2D28Q39038590-74717DFE-DD6D-4EE6-92FC-F1D17BA51BD1Q40073768-02E73756-033E-4B7B-95C1-355D4A561991Q40674877-81279853-ACBF-4D6F-8984-FA17307D28B7Q40913492-21BC4862-BC50-4784-802F-75F4D8CF3EA3Q41138033-8540C7A4-DD1F-42C4-BA59-FA53D2FCA05BQ47273518-B2E75575-EC03-4880-8E95-0809DA0A03F2Q53691904-79C3B111-DDB5-42C6-AD42-404BD23E1583Q57169312-FB603663-6CF8-487B-B0FE-966C65F7C62F
P2860
Amplification of aminoglycoside resistance gene aphA1 in Acinetobacter baumannii results in tobramycin therapy failure
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Amplification of aminoglycosid ...... in tobramycin therapy failure
@en
type
label
Amplification of aminoglycosid ...... in tobramycin therapy failure
@en
prefLabel
Amplification of aminoglycosid ...... in tobramycin therapy failure
@en
P2093
P2860
P356
P1433
P1476
Amplification of aminoglycosid ...... in tobramycin therapy failure
@en
P2093
Catherine Grillot-Courvalin
Emil Lesho
Erik Snesrud
Eun-Jeong Yoon
Fatma Onmus-Leone
Paige E Waterman
Patrice Courvalin
Robert J Clifford
Yoon I Kwak
P2860
P304
P356
10.1128/MBIO.00915-14
P577
2014-04-22T00:00:00Z